Editorial information aggregated from public sources. Not regulated investment advice.

All funds
FundVerifiedPro

Amgen

US biopharmaceutical company; participated in Quantinuum's $300M 2024 equity round as a strategic investor, alongside exploring quantum-computing applications for drug discovery.

Overview

Firm
Amgen Inc.
Headquarters
Thousand Oaks, CA
Founded
1980

Detailed portfolio and thesis data is available to Pro subscribers.

Request Pro access for full access to all five axes — complete cap tables, round-by-round history, and a cited source behind every claim.